Status:
ACTIVE_NOT_RECRUITING
Aortic Valve Neocuspidization With Glutaraldehyde-Treated Autologous Pericardium (Ozaki Procedure)
Lead Sponsor:
Maria Cecilia Hospital
Conditions:
Aortic Valve Disease
Eligibility:
All Genders
18+ years
Brief Summary
The Ozaki aortic valve reconstruction procedure uses autologous or bovine pericardium as an aortic cusp replacement without the use of struts and with use of the patient's own native aortic root. In t...
Eligibility Criteria
Inclusion
- severe aortic valve stenosis or insufficiency
- Written informed consent
- Willingness to carry out the follow-up visits
Exclusion
- Other types of aortic valve surgery
Key Trial Info
Start Date :
June 6 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 6 2027
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05411055
Start Date
June 6 2021
End Date
June 6 2027
Last Update
August 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MCH
Cotignola, Ravenna, Italy, 48033